Cargando…
Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis
BACKGROUND: The purpose of this comprehensive meta-analysis was to assess the association of aldehyde dehydrogenase (ALDH) expression with overall survival (OS) and disease-free survival (DFS)/progression-free survival (PFS) in ovarian cancer patients. METHODS: Systematic searches of Pubmed database...
Autores principales: | Xia, Yan, Wei, Xuemin, Gong, Hui, Ni, Yunxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284301/ https://www.ncbi.nlm.nih.gov/pubmed/30522488 http://dx.doi.org/10.1186/s12905-018-0686-x |
Ejemplares similares
-
Update on the aldehyde dehydrogenase gene (ALDH) superfamily
por: Jackson, Brian, et al.
Publicado: (2011) -
Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family
por: Vasiliou, Vasilis, et al.
Publicado: (2005) -
Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update
por: Panisello-Roselló, Arnau, et al.
Publicado: (2018) -
Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer
por: Ma, Yu-mei, et al.
Publicado: (2016) -
Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
por: Xia, Jie, et al.
Publicado: (2023)